Mesoblast International Sàrl

Suisse


Commandez votre montre hebdomadaire Mesoblast International Sàrl
Quantité totale PI 148
Rang # Quantité totale PI 8 971
Note d'activité PI 2,9/5.0    99
Rang # Activité PI 6 830
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

62 3
33 5
41 2
2
 
Dernier brevet 2025 - Treatment of immune disorders
Premier brevet 1990 - Method for enhancing the implant...
Dernière marque 2024 - RYONCIL
Première marque 2006 - PROCHYMAL

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Method for treating heart failure. The present disclosure relates to methods for treating or pre...
Invention Purified mesenchymal stem cell compositions and methods of purifying mesenchymal stem cell compos...
Invention Potency assay and manufacturing method ii. The present disclosure relates to improved cellular co...
Invention Treatment of immune disorders. The present disclosure relates to stem cells which express high l...
Invention Method for treating or preventing gastrointestinal bleeding. The present disclosure relates to m...
Invention Stem cell composition. The disclosure provides stem cells which express high levels of Angeopoet...
2024 Invention Cell culture method for mesenchymal stem cells. The present disclosure relates to methods, cell ...
P/S Clinical research in the field of pharmaceutical preparations and medicines; Consulting services ...
Invention Delivery catheter. A delivery catheter 100 configured to deliver a composition to a target site w...
Invention Mesenchymal lineage precursor or stem cells (mlpscs) for use in methods of treating congenital he...
Invention Prevention of progressive heart failure. The present disclosure relates to methods for preventin...
Invention Third line treatment for gvhd. The present disclosure relates to mesenchymal lineage precursor or...
Invention Potency assay. The present invention relates to a method for determining the biological activity...
Invention Apparatus, sleeve and method for holding vials comprising label retainer. An apparatus (100) for ...
Invention Potency assay and manufacturing method. The present disclosure relates to improved cellular compo...
2023 Invention Method of treating heart failure in subjects with persistent inflammation. The present disclosure...
Invention Method of treating inflammation with cellular compositions. The present disclosure relates to cel...
Invention Pre-licensed composition and cell culture methods. The present disclosure relates to MLPSC popula...
Invention Conditioned media and use of the same. The present disclosure relates to conditioned media and me...
Invention Mesenchymal stem cells expressing tnf-alpha receptors. Mesenchymal stem cells which express TNF-...
P/S Scientific research, clinical research and development in relation to pharmaceutical preparations...
Invention Cryopreserved intermediate and potency assay for same. The present disclosure relates to improved...
Invention Enhanced msc preparations. The present invention provides preparations of MSCs with important the...
Invention Mesenchymal progenitor cells for enhancing partial reprogramming of target cells. Provided herein...
Invention High flow filter and method of use. A filter is disclosed. The filter comprises: a flexible cont...
Invention High flow filter and method of use. A filter is disclosed. The filter comprises: a flexible conta...
Invention Method for treating heart failure. Methods for treating chronic heart failure due to left ventric...
Invention Cell culture method for mesenchymal stem cells. The present disclosure relates to a cell culture ...
2022 Invention Method of treating severe graft versus host disease. The present disclosure relates to mesenchym...
Invention Method of treating severe graft versus host disease. The present disclosure relates to mesenchyma...
Invention Method of treating progressive heart failure in subjects at high risk of poor outcomes. The pres...
Invention Prevention of progressive heart failure. The present disclosure relates to methods for preventing...
Invention Treatment of immune disorders. The present disclosure relates to stem cells which express high le...
Invention Mesenchymal stem cells and uses therefor. Compositions and methods of promoting wound healing in...
Invention Method for treating acute respiratory distress syndrome (ards) using mesenchymal lineage precurso...
Invention Method for treating acute respiratory distress syndrome (ards) in specific patients using mesench...
Invention Opioid sparing compositions and methods of using the same. The present disclosure relates to opi...
2021 Invention Method of treating progressive heart failure in subjects with class ii heart failure. The presen...
Invention Cellular compositions and methods of treatment. The present disclosure relates to cellular compo...
Invention A composition comprising mesenchymal precursor or stem cells and their use. The present disclosu...
Invention 3d culture of mesenchymal lineage precursor or stem cells. The present disclosure relates to imp...
Invention Method for treating hyperinflammation using mesenchymal lineage precursor or stem cells. The pre...
Invention Method for treating inflammatory bowel disease i. The present disclosure relates to method of tr...
Invention Method for treating inflammatory bowel disease ii. The present disclosure relates to method of t...
Invention Method for treating inflammatory lung diseases using mesenchymal lineage precursor or stem cells....
Invention Method for treating chronic graft versus host disease. The present disclosure relates to methods...
2020 Invention Cellular compositions comprising viral vectors and methods of treatment. The present disclosure ...
2019 P/S Pharmaceutical, biotechnology and medication preparations and substances for the prevention, mana...
P/S Pharmaceutical, biotechnology and medication preparations and substances for the prevention, man...
2006 P/S Pharmaceutical composition containing mesenchymal stem cells which may be administered intravenou...